Telomerase is an outstanding biological target for cancer treatment. BIBR1532 is a non- nucleoside selective telomerase inhibitor; however, it experiences ineligible …
Herein we report the synthesis of organic selenide-based maleanilic and succinanilic acids in good yields (up to 95%). Their structural identities were elucidated by spectroscopic …
Herein, modifications to the previously reported BIBR1591 were conducted to obtain bioisosteric candidates with improved activities. The% inhibition of the newly afforded …
Apparently, tubulin inhibitors binding to the colchicine-binding site (CBS) currently have outstanding attention for cancer treatment. So, a series of benzo [b] azonin-2-one derivatives …
COVID-19 infection is now considered one of the leading causes of human death. As an attempt towards the discovery of novel medications for the COVID-19 pandemic, nineteen …
The global outbreak of the COVID-19 pandemic provokes scientists to make a prompt development of new effective therapeutic interventions for the battle against SARS-CoV-2. A …
A Musa, SK Ihmaid, DL Hughes, MA Said… - Journal of …, 2023 - Taylor & Francis
Abstract Treatment options for the management of breast cancer are still inadequate. This inadequacy is attributed to the lack of effective targeted medications, often resulting in the …
Abstract Vascular Endothelial Growth Factor II (VEGFR-2) has been proved as a rational target in cancer therapy. Although currently prescribed VEGFR-2 inhibitors are showing …
In this research, two novel series of dibenzo [b, f] azepines (14 candidates) were designed and synthesised based on the rigidification principle and following the reported …